Lowers the risk of myocardial infarction, myocardial revascularization procedures, and…. ANDA 77987, held by Glenmark Pharms Ltd. Pravastatin Sodium.
As of Nov 16, 2026, ANDA 77987 (Pravastatin Sodium), held by Glenmark Pharms Ltd, was first approved by FDA on May 11, 2007, with 9 approved supplements and 0 published complete response letters.
Pravastatin sodium tablets are indicated: Pravastatin sodium tablets are an HMG-CoA reductase inhibitor (statin) indicated:
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 11, 2007 | Original application | Approved | None posted |
| Pravastatin Sodium10MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium20MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium40MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium80MG · tablet;oral | Pravastatin Sodium | Rx |
| Mar 18, 2025 | Supplement 23Labeling · Standard review | Approved | None posted |
| Mar 18, 2025 | Supplement 19Labeling · Standard review | Approved | None posted |
| Feb 1, 2021 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jun 30, 2017 | Supplement 13Labeling · Standard review | Approved | None posted |
| Oct 16, 2014 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jul 1, 2014 | Supplement 9Manufacturing | Approved | None posted |
| Jul 20, 2012 | Supplement 6Labeling · Standard review | Approved | None posted |
| Dec 28, 2007 | Supplement 2Labeling | Approved | None posted |
| Dec 28, 2007 | Supplement 1Manufacturing | Approved | None posted |
| May 11, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters